课题基金 / 基金详情

Pneumolysin, Innate and Acquired Immunity to Pneumococci

Pneumolysin, Innate and Acquired Immunity to Pneumococci
肺炎球菌溶血素、对肺炎球菌的先天性和获得性免疫
批准号:
6464594
负责人:
RICHARD MALLEY
金额:
$11.77万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2006-03-31

项目摘要

项目成果

RICHARD MALLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Streptococcus pneumoniae remains a major cause of morbidity and mortality worldwide. Two components of pneumococci are thought to be responsible for much of the deleterious inflammatory hot response, the thiol-activated secreted toxin pneumolysin and the peptidoglycan component of the ell wall. Both of these molecules have been shown to cause inflammatory changes in vitro studies in epithelial and neuronal cells, as well as activate monocytes and macrophages of the inactive immune system. Preliminary work in our laboratory supports the hypothesis that pneumolysin activates the innate arm of the immune system through a transmembrane receptor, Toll-like receptor 4 (TLR4), in synergy with peptidoglycan (a TLR2 ligand) and/or whole pneumococci. In addition, we have some preliminary data to suggest that the activation of the innate immune response by pneumolysin may greatly augment acquired immunity to pneumococcus as well. The scientific goals of this project are divided in two phases. In the first phase, the PI will study the TLR- dependent signaling pathway of pneumolysin, alone and in combination with peptidoglycan or whole pneumococci. Studies will be done to test the hypothesis that pneumolysin binds directly to TLR4. This phase will also include an intense didactic component, to complement the work in the laboratory. In the second phase, the PI will study the role of this pathway in the modulation of disease and acquired immunity to pneumococci. This phase of the project will test the hypothesis that TLR4-mediated cellular activation by pneumolysin plays an important role in the pathophysiology of pneumococcal disease. Pneumococci carrying mutations in the pneumolysin gene, with diminished or abrogated TLR4-signaling capability, will be studied both in vitro (in macrophages) and in vivo (in murine models of colonization and disease). The possible role of TLR4-mediated response to pneumolysin in the development of acquired immunity will be studied in the final aim of the proposal. The establishment of a link between the innate and the acquired arm of the immune response to pneumococcus may provide a better understanding of the mechanisms by which immunity to pneumococcus is acquired.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
  • 批准号:
    10316230
  • 项目类别:
  • 资助金额:
    $114.45万
  • 财政年份:
    2017
  • 负责人:
    RICHARD MALLEY
  • 依托单位:
S. pneumoniae pilus regulation and host response
  • 批准号:
    8893197
  • 项目类别:
  • 资助金额:
    $64.91万
  • 财政年份:
    2014
  • 负责人:
    RICHARD MALLEY
  • 依托单位:
Enhancing neonatal immunity to Streptococcus pneumoniae
  • 批准号:
    8299197
  • 项目类别:
  • 资助金额:
    $41.5万
  • 财政年份:
    2012
  • 负责人:
    RICHARD MALLEY
  • 依托单位:
Enhancing neonatal immunity to Streptococcus pneumoniae
  • 批准号:
    8639459
  • 项目类别:
  • 资助金额:
    $49.64万
  • 财政年份:
    2012
  • 负责人:
    RICHARD MALLEY
  • 依托单位:
海外基金